MIM
NUVL

MetLife Investment Management’s Nuvalent NUVL Stock Holding History

MetLife Investment Management’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.81M Sell
27,397
-234
-0.8% -$23.8K 0.01% 884
2025
Q4 		$2.78M Buy
27,631
+2,544
+10% +$251K 0.01% 908
2025
Q3 		$2.17M Sell
25,087
-619
-2% -$48.9K 0.01% 1049
2025
Q2 		$1.96M Buy
25,706
+4,943
+24% +$362K 0.01% 999
2025
Q1 		$1.47M Sell
20,763
-330
-2% -$25.8K 0.01% 1186
2024
Q4 		$1.65M Buy
21,093
+1,356
+7% +$127K 0.01% 1147
2024
Q3 		$2.02M Buy
19,737
+1,231
+7% +$102K 0.01% 1012
2024
Q2 		$1.4M Buy
18,506
+4,488
+32% +$319K 0.01% 1160
2024
Q1 		$1.05M Hold
14,018
– – 0.01% 1269
2023
Q4 		$1.03M Buy
14,018
+1,236
+10% +$76.5K 0.01% 1273
2023
Q3 		$588K Hold
12,782
– – ﹤0.01% 1534
2023
Q2 		$539K Buy
12,782
+1,880
+17% +$71.1K ﹤0.01% 1650
2023
Q1 		$284K Hold
10,902
– – ﹤0.01% 1999
2022
Q4 		$325K Sell
10,902
-2,057
-16% -$57.4K ﹤0.01% 1917
2022
Q3 		$252K Hold
12,959
– – ﹤0.01% 2137
2022
Q2 		$176K Hold
12,959
– – ﹤0.01% 2407
2022
Q1 		$180K Buy
12,959
+8,590
+197% +$125K ﹤0.01% 2414
2021
Q4 		$83.2K Hold
4,369
– – ﹤0.01% 2447
2021
Q3 		$98.5K Buy
+4,369
New +$127K ﹤0.01% 2446

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MetLife Investment Management's NUVL Position: Q1 2026 in Review

MetLife Investment Management reduced its Nuvalent (NUVL) stake by 0.85% in Q1 2026, selling an estimated $23.8K and leaving 27,397 shares worth $2.81M. The position accounts for 0.01% of the portfolio, ranked #884.

MetLife Investment Management first reported a position in NUVL in Q3 2021 and has held it in 19 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • MetLife Investment Management held 27,397 shares of Nuvalent worth $2.81M as of Q1 2026.
  • MetLife Investment Management sold 234 Nuvalent shares in Q1 2026, an estimated $23.8K.
  • Nuvalent made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #884 holding.
  • MetLife Investment Management first reported a position in Nuvalent in Q3 2021 and has held it in 19 quarters since.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.